Helix BioPharma Corp. Announces Fiscal 20...(------------------------ ...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Helix BioPharma Corp. Announces Fiscal 2008 Results
Date:10/28/2008
------------------------
(6,977) (5,858) (4,304)
Change in non-cash
working capital (20) (221) 202
------------------------
Operating activities (6,997) (6,079) (4,102)
Financing activities 14,614 6,480 8,808
Investing activities (266) 6,577 (4,428)
Effect of exchange rate
changes on cash and
cash equivalents 327 9 (16)
------------------------
Cash and cash equivalents:
Increase in the year 7,678 6,987 262
Beginning of the year 11,379 4,392 4,130
------------------------
End of the year 19,057 11,379 4,392
========================
Consolidated Balance Sheets (thousand $)
2008 2007
---------------
Current assets:
Cash and cash equivalents 19,057 11,379
Accounts receivable 349 902
Inventory 458 539
Prepaid and other 446 187
20,310 13,007
Non current assets 1,356 1,266
21,666 14,273
2008 2007
---------------
Current liabilities:
Accounts payable 598 565
Accrued liabilities 546 974
1,144 1,539
Shareholders' equity 20,522 12,734
21,666 14,273
The Company's complete 2008 Consolidated Financial Statements,
Manageme
'/>"/>
| SOURCE Helix BioPharma Corp. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Helix Biopharma Closes $11.4 Million Private Placement
2. Helix BioPharma Announces $11.4 Million Private Placement
3. Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canadas Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada
4. Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences
5. Helix BioPharma product development update, quarterly highlights and financial results for fiscal Q3 2008
6. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
7. Helix BioPharma reports Q2 2008 highlights, financial results
8. Helix BioPharma shareholders vote in favour of management
9. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
10. Helix BioPharma closes $16.9 million private placement of common shares
11. Helix BioPharma announces Q1 2008 financial results
Post Your Comments:
(Date:11/25/2009)...to Speak at Economic Club of Canada , ...2009 -- Ambassador to Speak at Economic Club of Ca...r for International Investment, and Chairman and C...aphy of David Appia go to www.investinfrance.org ...et with press to discuss recent pro-business initi...
(Date:11/25/2009)...25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA...nnounced today that it executed,a joint venture (J...,Technology Co., Ltd. (Sinovac Dalian). The JV wil...an-use vaccines. Sinovac will contribute its exper...ing world-class vaccines; the,other party will bri...
(Date:11/24/2009)...an . , Whether it,s CD packaging, containers...cy Identification) are increasingly finding their ...abel objects or goods and identify them automatica...n read and process the data contained in the label...ction conditions of up to 100 degrees Celsius. But...
(Date:11/24/2009)...k investment bank KTA Capital,s client Neuren Phar... convertible note private placement with a U.S. in...ranged by KTA Capital as Neuren,s exclusive placem...New York (PRWEB) November 23, 2009 -- The independ...ot;KTA Capital") has announced that its clien...
Breaking Biology Technology:French Ambassador for International Investment to Visit Toronto December 11 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2[1] French Ambassador for International Investment to Visit Toronto December 11[0] Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities[0] Intelligence inside metal components[0] KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals
...ration today announced that The Michael J. Fox Fou...lestones to support the Company,s collaboration wi...ecent discovery of a new target for the treatment ...brain responsible for Parkinson,s disease, Omeros ...ment of any movement disorder, including Parkinson...
...UCKLAND, New Zealand, Jan. 6 MicroDose Technologi...at they have entered into a collaboration to inves...e(TM) technology with MicroDose,s next generation ...rms of the agreement, MicroDose will fund the deve...er platform and incorporating Nexus6,s Smartinhale...
...o Corporation,(Nasdaq: VOLC ), a leader in the d...r the diagnosis and treatment of coronary and peri...participating in the 27th Annual J.P.,Morgan Healt...he presentation by Scott Huennekens, president and... Pacific Standard Time (11:30 a.m., Eastern,Standa...
Other Biology Technology:Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target 2Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease Target 3MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler 2MicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder Inhaler 3Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast 2Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinson's Disease TargetMicroDose and Nexus6 Announce Collaboration to Evaluate Application of Remote Patient Compliance Monitoring Technology with MicroDose's Electronic Dry Powder InhalerVolcano Corporation Presentation at J.P. Morgan Conference to be Webcast
(Date:11/25/2009)...t State University assistant professors recently r...on (NSF) to continue research beneficial to unders...90,000. , Christopher Blackwood, assistant profe... awarded grants to support two separate research p... Litter Decomposer Communities and Functions from ...
(Date:11/24/2009)...science is opening new doors to understanding how ... hearing of a marine mammal or if they hear it at...X-ray scanners that NASA uses to detect flaws in t...now allowing scientists to peek inside the giant h...hree-dimensional replicas of a whale,s hearing ana...
(Date:11/24/2009)...r and the American College of Medical Toxicology (...he publication of the Journal of Medical Toxicolo...ning in March 2010. It was previously published b...Journal of Medical Toxicology , an international, ...he science and practice of medical toxicology. Th...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Triple S Management Corporation Reports Third Quarter 2009 Results 60596 1Triple S Management Corporation Reports Third Quarter 2009 Results 60596 2Triple S Management Corporation Reports Third Quarter 2009 Results 60596 3Triple S Management Corporation Reports Third Quarter 2009 Results 60596 4Triple S Management Corporation Reports Third Quarter 2009 Results 60596 5Triple S Management Corporation Reports Third Quarter 2009 Results 60596 6Triple S Management Corporation Reports Third Quarter 2009 Results 60596 7Triple S Management Corporation Reports Third Quarter 2009 Results 60596 8Triple S Management Corporation Reports Third Quarter 2009 Results 60596 9Triple S Management Corporation Reports Third Quarter 2009 Results 60596 10Triple S Management Corporation Reports Third Quarter 2009 Results 60596 11Triple S Management Corporation Reports Third Quarter 2009 Results 60596 12Triple S Management Corporation Reports Third Quarter 2009 Results 60596 13Triple S Management Corporation Reports Third Quarter 2009 Results 60596 14Triple S Management Corporation Reports Third Quarter 2009 Results 60596 15Triple S Management Corporation Reports Third Quarter 2009 Results 60596 16VisualSonics Appoints New President and CEO 60594 1VisualSonics Appoints New President and CEO 60594 2Avizents New TeamCOMP Approach Helps Ensure Lower Workers Comp Costs and Faster Claims Resolution 60592 1Avizents New TeamCOMP Approach Helps Ensure Lower Workers Comp Costs and Faster Claims Resolution 60592 2... evolution and creationism are often shaped by wha...s, according to a University of Minnesota study pu...nal of the American Institute of Biological Scienc...rofessors in the College of Biological Sciences, s... classes at the University of Minnesota to learn h...
... the venomous murder of the mighty Thor, the serpe...e of mischief and misery. , The worldwide promin...erscores our deep connection to the serpentbut why... The surprising answer, University of California, ...ests, lies in the singular impact of snakes on pri...
...ral disease blighting many of the world,s tropical...gypti , 40% of the world,s population is believed ...evious exposure to other strains of the fever does...ions are significantly worse, and can result in fa...ioning vaccine forced Scott O,Neill and Elizabeth ...
Other Biology News:U of Minnesota study finds high school teachers influence student views of evolution & creationism 2Mosquito parasite may help fight dengue fever 2PROTEAN II XL Cell, wide format from Bio-Rad
StemSep Rat T Cells, 2 mL from StemCell Technologies, Inc.
F40 Piston Seals, 2 from Bio-Rad
StemSep Rhesus T Cell Purging, 2 mL Kit from StemCell Technologies, Inc.
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |